Oklahoma Gov. Kevin Stitt, state legislators and several Oklahoma cities have raised concerns about who would get the $85 million from a settlement the Oklahoma attorney general reached last month with opioid manufacturer Teva Pharmaceuticals Industries Ltd.

In an amicus brief filed Friday, the governor, along with Oklahoma House of Representatives Speaker Charles McCall and the state’s Senate President Pro Tempore Greg Treat, wrote that the Teva settlement did not comply with an Oklahoma law enacted last month that made it “unconstitutional for any settlement agreement to direct how, when or where the legislature appropriates state monies.”